OA05.05 Ifinatamab Deruxtecan (I-DXd; DS-7300) in Patients with Refractory SCLC: A Subgroup Analysis of a Phase 1/2 Study

• DOI: 10.1016/j.jtho.2023.09.042
• Publication Date: 2023-10-31T05:24:17Z
• Authors: M. Johnson; M. Awad; T. Koyama; M. Gutierrez; G.S. Falchook; S.A. Piha-Paul; T. Doi; T. Satoh; N. Okamoto; J. Singh; N. Yoshizuka; M. Qian; X. Qian; B.P. Tran; O. Dosunmu; R. Mucha; H. Windish; M.R. Patel
• Keywords: Refractory (planetary science); Linker; Payload (computing)